Strategic Considerations for Innovation and Commercialization in the US Biotechnology Sector-Reference-Cited by-同舟云学术

Strategic Considerations for Innovation and Commercialization in the US Biotechnology Sector

Published:2007-05-08 Issue:6 Volume:15 Page:753-766
ISSN:0965-4313
Container-title:European Planning Studies
language:en
Short-container-title:European Planning Studies

Author:

Bagchi-Sen Sharmistha

Publisher

Informa UK Limited

Subject

Geography, Planning and Development

Link

http://www.tandfonline.com/doi/pdf/10.1080/09654310701214226

Reference33 articles.

1. Knowledge spillovers in biotechnology: sources and incentives

2. The US Biotechnology Industry: Industry Dynamics and Policy

3. Burrill , G. S. 11 April 2006. “A changing prescription for biotechnology. Paper presented at BIO 2006”. 11 April, Chicago, IL Available athttp://www.burrillandco.com/burrill/pr_1144776165, accessed 22 April 2006.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolution of Orbital Implants and Current Breakthroughs in Material Design, Selection, Characterization, and Clinical Use;Frontiers in Bioengineering and Biotechnology;2022-02-17

2. The effect of collaboration with top-funded scholars on scientific production;Science and Public Policy;2020-01-14

3. Knowledge Transfers in the US Biopharmaceutical Market During a Time of Transition;Journal of Pharmaceutical Innovation;2019-05-04

4. From Invention Success to Commercialization Success: Technology Ventures and the Benefits of Upstream and Downstream Supply-Chain Alliances;Journal of Small Business Management;2017-03-13

5. Orbital implants: State-of-the-art review with emphasis on biomaterials and recent advances;Materials Science and Engineering: C;2016-12